Valuation Kwality Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. 03:40:51 2026-09-08 EDT			5-day change	1st Jan Change
3,669.85 ^INR	+7.56%		+7.77%	+229.39%

09-02	Kwality Pharmaceuticals Limited Appoints Swanith Kapoor, as the Non-Executive Independent Director, Effective 02 June, 2026	CI
08-10	Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	581.1	6,018	3,191	4,248	9,017	13,555
Change	-	935.71%	-46.97%	33.12%	112.27%	50.32%
Enterprise Value (EV) ¹	890.9	6,429	4,020	5,170	9,994	14,826
Change	-	621.62%	-37.47%	28.59%	93.32%	48.34%
P/E	3.84x	5.02x	16.5x	17.9x	22.6x	20.1x
PBR	0.95x	3.32x	1.59x	1.89x	3.42x	4.09x
PEG	-	0x	-0.2x	0.8x	0.3x	0.3x
Capitalization / Revenue	0.22x	1.31x	1.27x	1.38x	2.44x	2.69x
EV / Revenue	0.34x	1.4x	1.6x	1.68x	2.7x	2.95x
EV / EBITDA	2.95x	3.71x	6.52x	7.6x	12.2x	12.3x
EV / EBIT	3.76x	3.95x	8.61x	10.7x	15.7x	14.8x
EV / FCF	-31x	-28.5x	-15.5x	-39.5x	-155x	-27.5x
FCF Yield	-3.22%	-3.51%	-6.43%	-2.53%	-0.64%	-3.64%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	14.6	115.6	18.67	22.93	38.4	64.9
Distribution rate	-	-	-	-	-	-
Net sales ¹	2,631	4,579	2,510	3,072	3,702	5,031
EBITDA ¹	301.8	1,735	616.4	680.1	820.4	1,203
EBIT ¹	236.9	1,628	466.8	484.5	637.5	1,005
Net income ¹	151.5	1,200	193.7	238	398.5	673.5
Net Debt ¹	309.8	410.6	829	921.8	976.9	1,271
Reference price ²	56.00	580.00	307.55	409.40	869.05	1,306.35
Nbr of stocks (in thousands)	10,376	10,376	10,376	10,376	10,376	10,376
Announcement Date	9/7/21	9/7/22	9/8/23	8/31/24	8/18/25	8/9/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
KWALITY PHARMACEUTICALS LIMITED	-	-	-	-	374M
ELI LILLY AND COMPANY	32.72x	11.9x	24.26x	0.6%	1,024B
JOHNSON & JOHNSON	30.62x	-	-	1.95%	663B
ABBVIE INC.	32.73x	7.6x	15.8x	2.67%	453B
ROCHE HOLDING AG	19.22x	4.69x	11.6x	2.83%	349B
NOVARTIS AG	22.02x	5.68x	14.1x	2.82%	295B
ASTRAZENECA PLC	20.97x	4.3x	12.3x	2.05%	253B
AMGEN INC.	27.66x	7.14x	13.16x	2.31%	236B
NOVO NORDISK A/S	13.33x	4.82x	10.06x	3.78%	206B
GILEAD SCIENCES, INC.	-46.14x	6.65x	25.95x	2.18%	187B
Average	17.01x	6.60x	15.90x	2.35%	366.77B
Weighted average by Cap.	23.94x	7.98x	17.77x	1.96%